Impact of Opiate abuse on HIV-mediated Pulmonary Vascular Remodeling
Impact of Opiate abuse on HIV-mediated Pulmonary Vascular Remodeling
批准号:
9204520
负责人:
Navneet Kaur Dhillon
金额:
$51.4万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2020-06-30
关键词:
AccountingAcquired Immunodeficiency SyndromeAdultAntioxidantsApoptosisApoptoticArterial DisorderAutophagocytosisAutophagosomeBasic ScienceBlood VesselsCardiopulmonaryCardiovascular systemCellsChildCocaineComplementComplexDevelopmentDiagnosisDiseaseDrug abuseEndothelial CellsExcisionExposure toGene ExpressionGenesGenetic TranscriptionGoalsHIVHIV InfectionsHIV-1HealthHeartHematological DiseaseHeroinHumanIllicit DrugsImmunologic Deficiency SyndromesIn VitroIncidenceIndividualInterventionInvestigationLesionLesion by StageLinkLungMacacaMediatingMitochondriaMolecularMorbidity - disease rateMorphineNaloxoneNarcotic AntagonistsOpioidOrganellesOxidative StressPathogenesisPatientsPrevalenceProliferatingProteinsPulmonary vesselsRattusRegulationReportingResearchResistanceRisk FactorsRoleSIVSeveritiesSignal TransductionSourceStagingStructure of parenchyma of lungTestingTherapeutic InterventionTrans-ActivatorsTransgenic OrganismsUnited StatesVascular DiseasesVascular Endothelial CellVascular remodelingViralViral ProteinsVirusantiretroviral therapyattenuationbasecytotoxicdrug of abuseimprovedin vivoinhibitor/antagonistinnovationintravenous drug useintravenous drug userknock-downmortalitynon-drugnovelnovel therapeuticsopioid abusepreventpulmonary arterial hypertension
中文摘要
项目总结
英文摘要
Project Summary
Improved survival among human immuno-deficiency virus (HIV-1) infected individuals with the advent of
antiretroviral therapy has clearly led to serious increase in the prevalence of noninfectious complications. In
this regard, one of the most devastating sequelae is the development of pulmonary arterial hypertension in
HIV-infected individuals (HPAH). Intravenous drug use (IVDU) accounts for one-third of all new cases of AIDS
in the United States and has been identified as the most common risk factor in the individuals diagnosed with
HPAH. Our recent findings showing enhanced pulmonary vascular remodeling in HIV-infected lung tissues
from IV heroin and/or cocaine abusers and in -infected macaques exposed to
morphine indicate that illicit drugs and HIV-1 potentially act in concert to cause pulmonary arteriopathy.
Furthermore, SIV-infected morphine treated macaques were found to have increased number of apoptotic
endothelial cells in the early stage lesions, whereas complete occlusion by actively proliferating endothelial
simian immunodeficiency (SIV)
cells was observed in the advanced stage plexiform lesions.
This observation was further supported by our in-
vitro findings showing enhanced apoptosis followed by significantly increased proliferation of human pulmonary
endothelial cells on simultaneous treatment with HIV-
transactivator of transcription
(Tat) protein and morphine
compared to either treatment alone. Based on our recent findings, the hypothesis of our study is that the
combined exposure of pulmonary endothelial cells to HIV-protein(s) and morphine results in the induction of
autophagy that leads to enhanced proliferation of endothelial cells and severe pulmonary vascular remodeling.
This hypothesis will be tested by pursuing three specific aims. In the first aim we will evaluate the effect of HIV-
Tat and morphine on the oxidative stress mediated regulation of bulk autophagy in endothelial cells. In the
second aim, we propose to delineate the role of autophagy/mitophagy in Tat and morphine mediated enhanced
proliferation. Third aim will be focused on in-vivo investigation of PAH and autophagy in HIV-1 Tg rats with or
without morphine exposure. These studies are innovative because to the best of our knowledge it will be the
first attempt to understand the potential link between the role of autophagy/mitophagy in the morphine and
HIV-proteins mediated apoptosis resistant enhanced proliferation. The proposed research will enhance our
understanding of the fundamental mechanisms involved in the pathogenesis of HPAH and therefore is directly
responsive to RFA-HL-14-024 (Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood
(HLB) Diseases in Adults and Children).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug abuse and HIV-associated pulmonary vascular injury
-
批准号:10330405
-
项目类别:
-
资助金额:$60.05万
-
财政年份:2021
-
负责人:Navneet Kaur Dhillon
-
依托单位:
Drug abuse and HIV-associated pulmonary vascular injury
-
批准号:10799336
-
项目类别:
-
资助金额:$30.21万
-
财政年份:2021
-
负责人:Navneet Kaur Dhillon
-
依托单位:
Drug abuse and HIV-associated pulmonary vascular injury
-
批准号:10161471
-
项目类别:
-
资助金额:$68.95万
-
财政年份:2021
-
负责人:Navneet Kaur Dhillon
-
依托单位:
Drug abuse and HIV-associated pulmonary vascular injury
-
批准号:10539306
-
项目类别:
-
资助金额:$60.24万
-
财政年份:2021
-
负责人:Navneet Kaur Dhillon
-
依托单位:
Extracellular Vesicles and and HIV/cocaine associated cardiopulmonary dysfunction
-
批准号:9204218
-
项目类别:
-
资助金额:$41.14万
-
财政年份:2016
-
负责人:Navneet Kaur Dhillon
-
依托单位:
Impact of Opiate abuse on HIV-mediated Pulmonary Vascular Remodeling
-
批准号:9115350
-
项目类别:
-
资助金额:$48.86万
-
财政年份:2015
-
负责人:Navneet Kaur Dhillon
-
依托单位:
HIV/Cocaine mediated human pulmonary vascular remodeling: Role of BMPR signaling.
-
批准号:8508237
-
项目类别:
-
资助金额:$28.99万
-
财政年份:2012
-
负责人:Navneet Kaur Dhillon
-
依托单位:
HIV/Cocaine mediated human pulmonary vascular remodeling: Role of BMPR signaling.
-
批准号:8410671
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2012
-
负责人:Navneet Kaur Dhillon
-
依托单位:
HIV/Cocaine mediated human pulmonary vascular remodeling: Role of BMPR signaling.
-
批准号:8653959
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2012
-
负责人:Navneet Kaur Dhillon
-
依托单位:
PDGF-Receptor regulation in Cocaine and Tat mediated Smooth Muscle Hyperplasia
-
批准号:8231329
-
项目类别:
-
资助金额:$14.1万
-
财政年份:2011
-
负责人:Navneet Kaur Dhillon
-
依托单位:
PDGF-Receptor regulation in Cocaine and Tat mediated Smooth Muscle Hyperplasia
-
批准号:8138313
-
项目类别:
-
资助金额:$14.1万
-
财政年份:2011
-
负责人:Navneet Kaur Dhillon
-
依托单位:
Oral Delivery of Nanoparticles encapsulated with HIV-DNA Vaccine
-
批准号:7620665
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2008
-
负责人:Navneet Kaur Dhillon
-
依托单位:
Oral Delivery of Nanoparticles encapsulated with HIV-DNA Vaccine
-
批准号:7751263
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2008
-
负责人:Navneet Kaur Dhillon
-
依托单位:
海外基金